Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions

Integrative Biology (United Kingdom)

Volumn 5, Issue 1, 2013, Pages 74-86

  Bradbury, Michelle S ^a   Phillips, Evan ^a   Montero, Pablo H ^a   Cheal, Sarah M ^a   Stambuk, Hilda ^a   Durack, Jeremy C ^a   Sofocleous, Constantinos T ^a   Meester, Richard J C ^b   Wiesner, Ulrich ^c   Patel, Snehal ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Quest Medical Imaging BV   (Netherlands)

^c Cornell University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ASPARTIC ACID; CATHEPSIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER; GLYCINE; MATRIX METALLOPROTEINASE; NANOPARTICLE; SILICON DIOXIDE; TYROSINE; VASCULOTROPIN RECEPTOR;

CANCER CELL; CANCER STAGING; CANCER SURGERY; CLINICAL PRACTICE; FLUORESCENCE IMAGING; HEALTH CARE QUALITY; HUMAN; IN VITRO STUDY; INFLAMMATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MELANOMA CELL; NANOMEDICINE; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE BIOPSY; SURFACE CHARGE; TISSUE DISTRIBUTION; TREATMENT RESPONSE; TUMOR ABLATION; TUMOR MICROENVIRONMENT; TUMOR XENOGRAFT;

ANIMALIA;

EID: 84871789735     PISSN: 17579694     EISSN: 17579708     Source Type: Journal    
DOI: 10.1039/c2ib20174g     Document Type: Review

References (63)

1. ACS Cancer Facts & Figures, Atlanta GA, 2012
2. C. M. Balch et al., Prognostic factors analysis of 17-600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 2001 19 16 3622 3634
3. R. Weissleder Molecular imaging in cancer Science 2006 312 5777 1168 1171
4. G. J. Kelloff et al., Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin. Cancer Res. 2005 11 8 2785 2808
5. A. B. Erman et al., Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer 2012 118 4 1040 1047
6. H. Kobayashi et al., Simultaneous multicolor imaging of five different lymphatic basins using quantum dots Nano Lett. 2007 7 6 1711 1716
7. E. M. Sevick-Muraca et al., Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study Radiology 2008 246 3 734 741
8. L. M. Crane et al., Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results Gynecol. Oncol. 2011 120 2 291 295
9. J. C. Rasmussen et al., Lymphatic imaging in humans with near-infrared fluorescence Curr. Opin. Biotechnol. 2009 20 1 74 82
10. S. Keereweer et al., Detection of oral squamous cell carcinoma and cervical lymph node metastasis using activatable near-infrared fluorescence agents Arch. Otolaryngol., Head Neck Surg. 2011 137 6 609 615
11. U. Mahmood R. Weissleder Near-infrared optical imaging of proteases in cancer Mol. Cancer. Ther. 2003 2 5 489 496
12. P. Wunderbaldinger et al., Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe Eur. Radiol. 2003 13 9 2206 2211
13. J. P. Gleysteen et al., Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment Cancer Biol. Ther. 2007 6 8 1181 1185
14. S. B. Lee et al., Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging Clin. Cancer Res. 2008 14 12 3840 3849
15. K. P. Withrow et al., Assessment of bevacizumab conjugated to Cy5.5 for detection of head and neck cancer xenografts Technol. Cancer Res. Treat. 2008 7 1 61 66
16. Y. Koyama et al., A dendrimer-based nanosized contrast agent dual-labeled for magnetic resonance and optical fluorescence imaging to localize the sentinel lymph node in mice J. Magn. Reson. Imaging 2007 25 4 866 871
17. H. Kobayashi et al., Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging J. Controlled Release 2006 111 3 343 351
18. R. T. Lucarelli et al., New approaches to lymphatic imaging Lymphatic Res. Biol. 2009 7 4 205 214
19. R. Jain et al., Diagnostic nanocarriers for sentinel lymph node imaging J. Controlled Release 2009 138 2 90 102
20. A. M. Wallace et al., Lymphoseek: a molecular radiopharmaceutical for sentinel node detection Ann. Surg. Oncol. 2003 10 5 531 538
21. Y. Hama et al., Two-color lymphatic mapping using Ig-conjugated near infrared optical probes J. Invest. Dermatol. 2007 127 10 2351 2356
22. S. P. Povoski et al., Multimodal Imaging and Detection Strategy With 124 I-Labeled Chimeric Monoclonal Antibody cG250 for Accurate Localization and Confirmation of Extent of Disease During Laparoscopic and Open Surgical Resection of Clear Cell Renal Cell Carcinoma Surg. Innov. 2012 10.1177/1553350612438416
23. R. K. Jain T. Stylianopoulos Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 2010 7 11 653 664
24. S. Keereweer et al., Optical image-guided surgery - where do we stand? Mol. Imaging Biol. 2011 13 2 199 207
25. L. Sampath et al., Near infrared fluorescent optical imaging for nodal staging J. Biomed. Opt. 2008 13 4 041312
26. A. Schroeder et al., Treating metastatic cancer with nanotechnology Nat. Rev. Cancer 2012 12 1 39 50
27. A. P. Yudd et al., Use of sentinel node lymphoscintigraphy in malignant melanoma Radiographics 1999 19 343 353
28. G. Ravizzini et al., Nanoparticles in sentinel lymph node mapping Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. 2009 1 6 610 623
29. O. Khullar et al., Image-guided sentinel lymph node mapping and nanotechnology-basesd nodal treatment in lung cancer using invisible near-infrared fluorescent light Semin. Thorac. Cardiovasc. Surg. 2009 21 4 309 315
30. R. Madru et al., 99mTc-labeled superparamagnetic iron oxide nanoparticles for multimodality SPECT/MRI of sentinel lymph nodes J. Nucl. Med. 2012 53 3 459 463
31. E. S. Olson et al., Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases Proc. Natl. Acad. Sci. U. S. A. 2010 107 9 4311 4316
32. M. Benezra et al., Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma J. Clin. Invest. 2011 121 7 2768 2780
33. A. A. Burns et al., Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine Nano Lett. 2009 9 1 442 448
34. J. Choi et al., Core-shell silica nanoparticles as fluorescent labels for nanomedicine J. Biomed. Opt. 2007 12 6 064007
35. A. Burns et al., Fluorescent core-shell silica nanoparticles: towards "Lab on a Particle" architectures for nanobiotechnology Chem. Soc. Rev. 2006 35 11 1028 1042
36. M. L. Misfeldt D. R. Grimm Sinclair miniature swine: an animal model of human melanoma Vet. Immunol. Immunopathol. 1994 43 1-3 167 175
37. J. V. Jokerst S. S. Gambhir Molecular imaging with theranostic nanoparticles Acc. Chem. Res. 2011 44 10 1050 1060
38. E. Phillips O. Penate-Medina P. B. Zanzonico H. Ow R. D. Carvajal P. Mohan Y. Ye J. Humm H. Kalaigian H. Schoder W. H. Strauss S. M. Larson U. Wiesner M. S. Bradbury Clinical Translation of an Ultrasmall Inorganic Fluorescent Hybrid Nanoparticle Probe 2012
39. H. Kobayashi et al., Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging ACS Nano 2007 1 4 258 264
40. S. Ohnishi et al., Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping Mol. Imaging 2005 4 3 172 181
41. C. H. Choi et al., Targeting kidney mesangium by nanoparticles of defined size Proc. Natl. Acad. Sci. U. S. A. 2011 108 16 6656 6661
42. H. Maeda et al., Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 2000 65 1-2 271 284
43. D. Hanahan R. A. Weinberg The hallmarks of cancer Cell 2000 100 1 57 70
44. K. N. Sugahara et al., Tissue-penetrating delivery of compounds and nanoparticles into tumors Cancer Cell 2009 16 6 510 520
45. P. P. Karmali et al., Targeting of albumin-embedded paclitaxel nanoparticles to tumors Nanomedicine 2009 5 1 73 82
46. S. Ke et al., Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts Cancer Res. 2003 63 22 7870 7875
47. W. K. Moon et al., Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate Bioconjugate Chem 2003 14 3 539 545
48. S. Kossodo et al., Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT) Mol. Imaging Biol. 2010 12 5 488 499
49. T. B. Potocky et al., Cytoplasmic and nuclear delivery of a TAT-derived peptide and a beta-peptide after endocytic uptake into HeLa cells J. Biol. Chem. 2003 278 50 50188 50194
50. J. S. Wadia et al., Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis Nat. Med. 2004 10 3 310 315
51. S. M. Moghimi et al., Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 2001 53 2 283 318
52. R. W. Oxenhandler et al., Malignant melanoma in the Sinclair miniature swine: an autopsy study of 60 cases Am. J. Pathol. 1979 96 3 707 720
53. L. E. Millikan et al., Melanoma in Sinclair swine: a new animal model J. Invest. Dermatol. 1974 62 1 20 30
54. M. G. Lubner et al., Microwave tumor ablation: mechanism of action clinical results, and devices J. Vasc. Interv. Radiol. 2010 21 Suppl 8 S192 S203
55. J. P. Erinjeri T. W. Clark Cryoablation: mechanism of action and devices J Vasc Interv Radiol 2010 21 Suppl 8 S187 S191
56. P. Abitabile et al., Radiofrequency ablation permits an effective treatment for colorectal liver metastasis Eur. J. Surg. Oncol. 2007 33 1 67 71
57. F. F. Amersi et al., Long-term survival after radiofrequency ablation of complex unresectable liver tumors Arch. Surg. 2006 141 6 581 587
58. M. A. Farrell et al., Imaging-guided radiofrequency ablation of solid renal tumors AJR, Am. J. Roentgenol. 2003 180 6 1509 1513
59. K. Hong C. Georgiades Radiofrequency ablation: mechanism of action and devices J Vasc Interv Radiol 2010 21 Suppl 8 S179 S186
60. G. S. Anderson et al., FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation Clin. Nucl. Med. 2003 28 3 192 197
61. N. C. Purandare et al., Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings Radiographics 2011 31 1 201 213
62. D. W. Barker et al., Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT AJR Am J Roentgenol 2005 184 4 1096 1102
63. F. M. Vogt et al., Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT J. Nucl. Med. 2007 48 11 1836 1844